STARRETT (L.S.) CO -CL A (SCX) Fundamental Analysis & Valuation

NYSE:SCX • US8556681091

Current stock price

16.18 USD
+0.01 (+0.06%)
Last:

This SCX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SCX Profitability Analysis

1.1 Basic Checks

  • In the past year SCX was profitable.
  • SCX had a positive operating cash flow in the past year.
  • Of the past 5 years SCX 4 years were profitable.
  • SCX had a positive operating cash flow in 4 of the past 5 years.
SCX Yearly Net Income VS EBIT VS OCF VS FCFSCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

  • SCX has a Return On Assets of 10.38%. This is amongst the best in the industry. SCX outperforms 83.08% of its industry peers.
  • The Return On Equity of SCX (14.81%) is better than 70.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.46%, SCX is in line with its industry, outperforming 56.92% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SCX is in line with the industry average of 10.17%.
Industry RankSector Rank
ROA 10.38%
ROE 14.81%
ROIC 7.46%
ROA(3y)9.28%
ROA(5y)3.69%
ROE(3y)16.98%
ROE(5y)2.17%
ROIC(3y)10.36%
ROIC(5y)7.65%
SCX Yearly ROA, ROE, ROICSCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40

1.3 Margins

  • SCX has a better Profit Margin (7.72%) than 61.54% of its industry peers.
  • With a Operating Margin value of 5.64%, SCX perfoms like the industry average, outperforming 41.54% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SCX has grown nicely.
  • SCX has a Gross Margin (31.48%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of SCX has remained more or less at the same level.
Industry RankSector Rank
OM 5.64%
PM (TTM) 7.72%
GM 31.48%
OM growth 3Y77.51%
OM growth 5Y28.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y0.19%
SCX Yearly Profit, Operating, Gross MarginsSCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. SCX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SCX is still creating some value.
  • The number of shares outstanding for SCX has been increased compared to 1 year ago.
  • The debt/assets ratio for SCX has been reduced compared to a year ago.
SCX Yearly Shares OutstandingSCX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
SCX Yearly Total Debt VS Total AssetsSCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

  • SCX has an Altman-Z score of 4.24. This indicates that SCX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of SCX (4.24) is better than 71.54% of its industry peers.
  • The Debt to FCF ratio of SCX is 0.50, which is an excellent value as it means it would take SCX, only 0.50 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.50, SCX belongs to the best of the industry, outperforming 91.54% of the companies in the same industry.
  • A Debt/Equity ratio of 0.02 indicates that SCX is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.02, SCX belongs to the best of the industry, outperforming 82.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.5
Altman-Z 4.24
ROIC/WACC0.81
WACC9.21%
SCX Yearly LT Debt VS Equity VS FCFSCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

  • SCX has a Current Ratio of 3.11. This indicates that SCX is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.11, SCX is doing good in the industry, outperforming 76.15% of the companies in the same industry.
  • A Quick Ratio of 1.42 indicates that SCX should not have too much problems paying its short term obligations.
  • The Quick ratio of SCX (1.42) is better than 63.85% of its industry peers.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 1.42
SCX Yearly Current Assets VS Current LiabilitesSCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. SCX Growth Analysis

3.1 Past

  • SCX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.20%, which is quite impressive.
  • Looking at the last year, SCX shows a decrease in Revenue. The Revenue has decreased by -2.50% in the last year.
  • The Revenue has been growing slightly by 3.44% on average over the past years.
EPS 1Y (TTM)33.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.51%
Revenue 1Y (TTM)-2.5%
Revenue growth 3Y8.33%
Revenue growth 5Y3.44%
Sales Q2Q%-7.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCX Yearly Revenue VS EstimatesSCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

Find the best growth stocksShow best growing peers

5

4. SCX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.32, which indicates a rather cheap valuation of SCX.
  • Based on the Price/Earnings ratio, SCX is valued cheaper than 95.38% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.50. SCX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.32
Fwd PE N/A
SCX Price Earnings VS Forward Price EarningsSCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SCX indicates a rather cheap valuation: SCX is cheaper than 91.54% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, SCX is valued cheaply inside the industry as 96.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.15
EV/EBITDA 5.98
SCX Per share dataSCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SCX Dividend Analysis

5.1 Amount

  • SCX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SCX Fundamentals: All Metrics, Ratios and Statistics

STARRETT (L.S.) CO -CL A

NYSE:SCX (5/22/2024, 8:04:00 PM)

16.18

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-06
Earnings (Next)09-13
Inst Owners0.39%
Inst Owner Change0%
Ins Owners1.65%
Ins Owner Change0%
Market Cap121.51M
Revenue(TTM)251.67M
Net Income(TTM)19.43M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.32
Fwd PE N/A
P/S 0.48
P/FCF 8.15
P/OCF 4.38
P/B 0.93
P/tB 0.97
EV/EBITDA 5.98
EPS(TTM)2.56
EY15.82%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.99
FCFY12.27%
OCF(TTM)3.69
OCFY22.81%
SpS33.51
BVpS17.46
TBVpS16.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 10.38%
ROE 14.81%
ROCE 9.41%
ROIC 7.46%
ROICexc 7.75%
ROICexgc 8.08%
OM 5.64%
PM (TTM) 7.72%
GM 31.48%
FCFM 5.93%
ROA(3y)9.28%
ROA(5y)3.69%
ROE(3y)16.98%
ROE(5y)2.17%
ROIC(3y)10.36%
ROIC(5y)7.65%
ROICexc(3y)11.22%
ROICexc(5y)8.32%
ROICexgc(3y)11.72%
ROICexgc(5y)8.76%
ROCE(3y)13.07%
ROCE(5y)9.65%
ROICexgc growth 3Y86.71%
ROICexgc growth 5Y30.58%
ROICexc growth 3Y87.08%
ROICexc growth 5Y32.25%
OM growth 3Y77.51%
OM growth 5Y28.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y0.19%
F-Score6
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.5
Debt/EBITDA 0.15
Cap/Depr 199.08%
Cap/Sales 5.09%
Interest Coverage 12.47
Cash Conversion 134.39%
Profit Quality 76.76%
Current Ratio 3.11
Quick Ratio 1.42
Altman-Z 4.24
F-Score6
WACC9.21%
ROIC/WACC0.81
Cap/Depr(3y)116.97%
Cap/Depr(5y)119.33%
Cap/Sales(3y)3.09%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.5%
Revenue growth 3Y8.33%
Revenue growth 5Y3.44%
Sales Q2Q%-7.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.78%
EBIT growth 3Y92.3%
EBIT growth 5Y32.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y256.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1255.04%
OCF growth 3YN/A
OCF growth 5Y43.93%

STARRETT (L.S.) CO -CL A / SCX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for STARRETT (L.S.) CO -CL A?

ChartMill assigns a fundamental rating of 5 / 10 to SCX.


What is the valuation status of STARRETT (L.S.) CO -CL A (SCX) stock?

ChartMill assigns a valuation rating of 5 / 10 to STARRETT (L.S.) CO -CL A (SCX). This can be considered as Fairly Valued.


How profitable is STARRETT (L.S.) CO -CL A (SCX) stock?

STARRETT (L.S.) CO -CL A (SCX) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for SCX stock?

The Price/Earnings (PE) ratio for STARRETT (L.S.) CO -CL A (SCX) is 6.32 and the Price/Book (PB) ratio is 0.93.